机构:[1]Clinical Medical Research Center, The Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Jinan University, Shenzhen, China深圳市人民医院深圳医学信息中心[2]Institute of Nephrology and Blood Purification, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China[3]Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes and MOE Key Laboratory of Tumor Molecular Biology, Institute of Life and Health Engineering, Jinan University, Guangzhou, China[4]Department of Nephrology, Dongguan Hospital of Guangzhou University of Traditional Chinese Medicine, Dongguan, China深圳市中医院深圳医学信息中心[5]Guangxi Key Laboratory of Metabolic Diseases Research, Affiliated No. 924 Hospital, Southern Medical University, Guilin, China
Science and Technology Plan of
Shenzhen (JCYJ20200109144218597, JCYJ20190807145815129),
Guangxi Key Laboratory of Metabolic Diseases Research (20-
065-76), Guangzhou Science and Technology Program
(201802030010), Guangdong Engineering Technology Research
Center (507204531040), and Dongguan Social Science and
Technology Development Project (201950715002195), and
National Natural Science Funds of China (81802916).
第一作者机构:[1]Clinical Medical Research Center, The Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Jinan University, Shenzhen, China[2]Institute of Nephrology and Blood Purification, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China
共同第一作者:
通讯作者:
通讯机构:[1]Clinical Medical Research Center, The Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Jinan University, Shenzhen, China[5]Guangxi Key Laboratory of Metabolic Diseases Research, Affiliated No. 924 Hospital, Southern Medical University, Guilin, China
推荐引用方式(GB/T 7714):
Li Yixi,Li Dehua,Chen Yang,et al.Robust Glycogene-Based Prognostic Signature for Proficient Mismatch Repair Colorectal Adenocarcinoma.[J].FRONTIERS IN ONCOLOGY.2021,11:doi:10.3389/fonc.2021.727752.
APA:
Li Yixi,Li Dehua,Chen Yang,Lu Yongping,Zhou Fangbin...&Dai Yong.(2021).Robust Glycogene-Based Prognostic Signature for Proficient Mismatch Repair Colorectal Adenocarcinoma..FRONTIERS IN ONCOLOGY,11,
MLA:
Li Yixi,et al."Robust Glycogene-Based Prognostic Signature for Proficient Mismatch Repair Colorectal Adenocarcinoma.".FRONTIERS IN ONCOLOGY 11.(2021)